| Tobacco industry lawyers as "disease vectors". | |
| | |
MedLine Citation:
|
PMID: 17652236 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Despite their obligation to do so, tobacco companies often failed to conduct product safety research or, when research was conducted, failed to disseminate the results to the medical community and to the public. The tobacco company lawyers' role in these actions was investigated with a focus on their involvement in company scientific research, claims of attorney-client privilege and work-product cover, document concealment, and litigation tactics. METHODS: Searches of previously secret internal tobacco industry documents located at Tobacco Documents Online. Additional searches included court transcripts, legal cases and articles obtained through Westlaw, PubMed, and the internet. RESULTS: Tobacco company lawyers have been involved in activities having little or nothing to do with the practice of law, including gauging and attempting to influence company scientists' beliefs, vetting in-house scientific research, and instructing in-house scientists not to publish potentially damaging results. Additionally, company lawyers have taken steps to manufacture attorney-client privilege and work-product cover to assist their clients in protecting sensitive documents from disclosure, have been involved in the concealment of such documents, and have employed litigation tactics that have largely prevented successful lawsuits against their client companies. CONCLUSIONS: Tobacco related diseases have proliferated partly because of tobacco company lawyers. Their tactics have impeded the flow of information about the dangers of smoking to the public and the medical community. Additionally, their extravagantly aggressive litigation tactics have pushed many plaintiffs into dropping their cases before trial, thus reducing the opportunities for changes to be made to company policy in favour of public health. Stricter professional oversight is needed to ensure that this trend does not continue. |
| | |
Authors:
|
Sara D Guardino; Richard A Daynard |
Related Documents
:
|
18243586 - Location and longing: the nicotine craving experience in virtual reality. 11866166 - The drd4 vntr polymorphism influences reactivity to smoking cues. 16997146 - Regulating biopharmaceuticals under cder versus cber: an insider's perspective. 20017206 - The role of entrepreneurial activities in academic pharmaceutical science research. 20465076 - Patients' expressed and unexpressed needs for information for informed consent. 11728626 - Recruitment strategies in the asthma clinical research network. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Review |
Journal Detail:
|
Title: Tobacco control Volume: 16 ISSN: 1468-3318 ISO Abbreviation: Tob Control Publication Date: 2007 Aug |
Date Detail:
|
Created Date: 2007-07-26 Completed Date: 2007-12-27 Revised Date: 2010-09-15 |
Medline Journal Info:
|
Nlm Unique ID: 9209612 Medline TA: Tob Control Country: England |
Other Details:
|
Languages: eng Pagination: 224-8 Citation Subset: IM |
Affiliation:
|
Public Health Advocacy Institute, 102 The Fenway, Cushing Hall Suite 117, Boston, MA 02115, USA. saraguardino@phaionline.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biomedical Research
/
legislation & jurisprudence Conflict of Interest Consumer Product Safety Humans Lawyers / standards* Professional Misconduct Smoking / adverse effects, legislation & jurisprudence Tobacco Industry / legislation & jurisprudence*, standards Truth Disclosure |
| Grant Support | |
ID/Acronym/Agency:
|
1 R01 CA87571/CA/NCI NIH HHS |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Venous ulcers of the lower limbs due to congenital thalidomide-related valve defect.
Next Document: Second-hand tobacco smoke in public places in urban and rural China.